Cdc42-and rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling

被引:158
作者
Koh, Wonshill [1 ]
Mahan, Rachel D. [1 ]
Davis, George E. [1 ,2 ]
机构
[1] Univ Missouri, Sch Med, Dalton Cardiovasc Res Ctr, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA
[2] Univ Missouri, Sch Med, Dalton Cardiovasc Res Ctr, Dept Pathol & Anat Sci, Columbia, MO 65212 USA
关键词
EC lumen formation; Rho GTPases; Pak; polarity; PKC;
D O I
10.1242/jcs.020693
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rho GTPases regulate a diverse spectrum of cellular functions involved in vascular morphogenesis. Here, we show that Cdc42 and Rac1 play a key role in endothelial cell (EC) lumen and tube formation as well as in EC invasion in three-dimensional (3D) collagen matrices and that their regulation is mediated by various downstream effectors, including Pak2, Pak4, Par3 and Par6. RNAi-mediated or dominant-negative suppression of Pak2 or Pak4, two major regulators of cytoskeletal signaling downstream of Cdc42 or Rac1, markedly inhibits EC lumen and tube formation. Both Pak2 and Pak4 phosphorylation strongly correlate with the lumen formation process in a manner that depends on protein kinase C (PKC)-mediated signaling. We identify PKC epsilon and PKC zeta as regulators of EC lumenogenesis in 3D collagen matrices. Two polarity proteins, Par3 and Par6, are also required for EC lumen and tube formation, as they establish EC polarity through their association with Cdc42 and atypical PKC. In our model, disruption of any member in the Cdc42-Par3-Par6-PKC zeta polarity complex impairs EC lumen and tube formation in 3D collagen matrices. This work reveals novel regulators that control the signaling events mediating the crucial lumen formation step in vascular morphogenesis.
引用
收藏
页码:989 / 1001
页数:13
相关论文
共 93 条
[91]   Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels [J].
Yang, S ;
Graham, J ;
Kahn, JW ;
Schwartz, EA ;
Gerritsen, ME .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) :887-895
[92]  
Yoshiji H, 1999, CANCER RES, V59, P4413
[93]   Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo [J].
Zhang, YF ;
Li, JY ;
Partovian, C ;
Sellke, FW ;
Simons, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (06) :H2078-H2082